News and Press Releases
ERS: Dupixent data reinforce clinically meaningful benefit from pooled analysis of two COPD phase 3 studies
Pooled results from the BOREAS and NOTUS studies show meaningful clinical benefit with 31% reduction in exacerbations along with lung function improvement Data from these two phase 3 studies supported...
Category: Clinical Trials, Drug Delivery, Pharmaceutical
Posted: September 10, 2024
Expert Speaker Line-Up Revealed for Industry-Leading RBQM Event
CluePoints Supports Launch of RBQMLive 2024 as Premier Event Sponsor 4 September 2024 -- Pennsylvania, US -- CluePoints, the premier sponsor of RBQMLive and provider of Risk-Based Quality Management (RBQM) and...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 4, 2024
SGS Introduces New Specialized Bioanalytical Testing Services in North America
21 August 2024 -- Geneva, Switzerland -- SGS, the world’s leading testing, inspection and certification company, announces the introduction of new specialized bioanalytical testing services in the North American pharmaceutical...
Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: August 21, 2024
New Medable Studio Empowers Sponsors to Launch eCOA Solutions into Clinical Trials with Unparalleled Control and Efficiency
Medable Studio for eCOA now available; two top-10 pharma company early adopters 14 August 2024 -- California, US -- Medable Inc, the leading technology platform for clinical trials, today announced...
Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: August 14, 2024
COREX Logistics Appoints New CEO to Expand Global Growth
Clinical trial and pharmaceutical logistics specialists COREX Logistics have announced the appointment of Steve Healy as its new CEO of the organisation. Healy, COREX Logistics’ former Vice President of Business...
Category: Clinical Trials, Logistics, Other
Posted: July 30, 2024
Suite 40, The Guinness Enterprise Centre, Taylors Lane, Dublin 8, Ireland
CHMP recommends RYBREVANT®▼ (amivantamab) in combination with chemotherapy for the treatment of adult patients with advanced EGFR-mutated non-small cell lung cancer (NSCLC) after failure of prior therapy
Patients with EGFR ex19del or EGFR L858R mutations, the most common EGFR mutations in NSCLC, currently face a poor prognosis and limited treatment options after disease progression on osimertinib1,2,3,4 ...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: July 26, 2024
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
Johnson & Johnson Receives Positive CHMP Opinion for Yuvanci® (Single Tablet Combination Therapy [STCT] of Macitentan and Tadalafil) for Treatment of Patients with Pulmonary Arterial Hypertension (PAH)
If approved, Yuvanci® would become the only single tablet combination for treatment for patients with PAH Johnson & Johnson’s comprehensive PAH portfolio has the potential to cover all guideline-recommended treatment...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: July 26, 2024
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience
AI-enhanced solution will help Eisai accelerate data review and reconciliation by 80% New York – July 25, 2024 – Medidata, a Dassault Systèmes brand and leading provider of clinical trial...
Category: Clinical Trials, Other, Pharmaceutical
Posted: July 25, 2024
Advarra Brings Together Clinical Trial Patient Recruitment Activities to Centralize Visibility and Accelerate Enrolment
New capability provides sponsors and CROs holistic view of sites’ patient recruitment progress 24 July 2024 -- COLUMBIA, MD – – Advarra, the market leader in regulatory review solutions and...
Category: Clinical Trials, Drug Discovery, Other
Posted: July 24, 2024
Broken String Biosciences appoints Steve Becker as Chief Commercial Officer
Appointment brings extensive experience to lead commercial operations and accelerate growth in key global markets Cambridge, UK, 24 July 2024: Broken String Biosciences (“Broken String”), a genomics company driving development...
Category: BioManufacturing
Posted: July 24, 2024
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR
Cherwell appoints new director of operations following retirement of Martyn Young
Newly appointed Andy Charteris to help company focus on continuous improvement initiatives 18 July 2024 -- Bicester, UK -- Cherwell, cleanroom microbiology solutions expert, is pleased to announce the appointment...
Category: BioManufacturing, Drug Discovery, Other, Pharmaceutical
Posted: July 18, 2024
Launton Business Centre Murdock Rd, Bicester OX26 4XB
Avallano releases ProtocolCopilot: Powering Clinical Research with AI-driven Protocol Assistance
16 July 2024 -- South Carolina, US -- Avallano is launching ProtocolCopilot, an innovative AI-driven clinical research protocol assistant designed to transform the way biopharmaceutical companies and clinical research sites...
Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: July 16, 2024
Optibrium Appoints James Halle as chief commercial officer
Key appointment brings extensive software commercial experience to drive global growth 16 July 2024 – Cambridge, UK – Optibrium, a leading developer of software and AI solutions for drug discovery...
Category: Drug Discovery
Posted: July 16, 2024
Optibrium Ltd. 7221 Cambridge Research Park, Beach Drive, Cambridge, CB25 9TL, UK
Signant Health Appoints 20-Year Life Sciences Veteran Paul Richmond to executive leadership team as chief commercial officer
15 July 2024 – Pennsylvania, US – Signant Health, the leader in evidence generation for modern clinical trials, announced today the appointment of Paul Richmond as chief commercial officer. A...
Category: Clinical Trials, Other, Pharmaceutical
Posted: July 16, 2024
Mogrify appoints Dr Jonathan Appleby as chief scientific officer
Strategic hire bolsters executive leadership team as company progresses multiple therapeutic programmes toward and into clinical development 15 July 2024 – Cambridge, UK – Mogrify, a regenerative medicine company developing...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: July 15, 2024
